Evaluation of the analgesic effect after extracorporeal shock with shock waves

Evaluation of the analgesic effect of oral administration of Acetaminophen + Oxycodone after extracorporeal shock with shock waves

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190624043991N18

Enrollment

150

Registered

2022-09-28

Start date

2022-11-11

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral stone. Calculus of lower urinary tract

Interventions

Intervention 1: Intervention group: Acetaminophen 325 + oxycodone 5 + diclofenac suppository (100 mg). Intervention 2: Intervention group: Diclofenac suppository (100 mg) + placebo.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ASA=II Consent to participate in the study Kidney stones between 4 and 20 mm No history of previous open surgery No history of previous crusher

Exclusion criteria

Exclusion criteria: Increased serum creatinine (more than 2 mg/dL) Urinary tract infection High grade hydronephrosis Diabetic Taking NSAIDs, acetaminophen and acetaminophen codeine in the previous 24 hours History of peptic ulcer Taking peptic ulcer pills G6PD deficiency History of liver and kidney disease History of drug allergy drug addiction

Design outcomes

Primary

Measure	Time frame
Pain control. Timepoint: Immediately, half an hour and a week after extracorporeal shock with shock waves. Method of measurement: Visual analogue scale questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Akram Mirzaei

Tehran University of Medical Sciences

mirzaee.scholar@gmail.com+98 21 6634 8560

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026